CIK 0001196298 · Non-accelerated filer<br>Smaller reporting company
NEPHROS INC
Sign in to watch- Ticker
- NEPH
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133971809
- Phone
- 201.343.5202
- Business address
- 380 LACKAWANNA PLACE, SOUTH ORANGE, NJ, 07079
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-16 | Lobo Wesley S. Chief Marketing Officer | Shares withheld for taxes | −6,389 | $4.80 | $31K | 35,168 |
| 2021-12-14 | Lask Alisa Director | Grant or award | +4,582 | 11,725 | ||
| 2021-12-14 | Lask Alisa Director | Grant or award · Stock Option (right to buy) | +7,062 | 7,062 | ||
| 2021-12-14 | Gwydir Tom Director | Grant or award | +4,582 | 15,613 | ||
| 2021-12-14 | Gwydir Tom Director | Grant or award · Stock Option (right to buy) | +7,062 | 7,062 | ||
| 2021-12-14 | Spandow Oliver J. Director | Grant or award | +5,429 | 24,829 | ||
| 2021-12-14 | Spandow Oliver J. Director | Grant or award · Stock Option (Right to Buy) | +7,062 | 7,062 | ||
| 2021-12-14 | Amron Arthur H Director | Grant or award | +4,582 | 4,582 | ||
| 2021-12-14 | Amron Arthur H Director | Grant or award · Stock Option (Right to Buy) | +7,062 | 7,062 | ||
| 2021-12-14 | Astor Andrew President & CEO | Grant or award · Stock Option (right to buy) | +38,612 | 38,612 | ||
| 2021-09-01 | Lobo Wesley S. Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +57,368 | 57,368 | ||
| 2021-08-20 | Lobo Wesley S. Chief Marketing Officer | Purchase | +1,000 | $7.92 | $8K | 41,557 |
| 2021-08-18 | Gwydir Tom Director | Purchase | +5,000 | $7.64 | $38K | 11,031 |
| 2021-08-18 | Astor Andrew President & CEO | Purchase | +2,500 | $7.77 | $19K | 77,958 |
| 2021-08-17 | Astor Andrew President & CEO | Purchase | +2,500 | $7.67 | $19K | 75,458 |
| 2021-06-01 | WEXFORD CAPITAL LP Director | Option exercise | +66,667 | $2.70 | $180K | 3,544,492 |
| 2021-06-01 | WEXFORD CAPITAL LP Director | Option exercise · Common Stock Warrants | −66,667 | $2.70 | $180K | 0 |
| 2021-05-27 | Evans Daron CEO Specialty Renal Products | Shares withheld for taxes | −349 | $2.70 | $942 | 8,947 |
| 2021-05-27 | Evans Daron CEO Specialty Renal Products | Shares withheld for taxes | −349 | $2.70 | $942 | 8,669 |
| 2021-05-24 | Evans Daron CEO of Specialty Renal Product | Option exercise | +1,111 | $2.70 | $3K | 9,296 |
Page 4 of 8 · 158 trades